Cortical spreading depression: A model for understanding migraine biology and future drug targets

Headache Currents

Volumn 2, Issue 5, 2005, Pages 97-103

  Haerter, Katharina ^a,c   Ayata, Cenk ^a,b   Moskowitz, Michael A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cerebral ischemia; CSD; FHM (familial hemiplegic migraine); Migraine without aura

Indexed keywords

ACEBUTOLOL; ACETAZOLAMIDE; ALIPHATIC HYDROCARBON; ALPRENOLOL; AMITRIPTYLINE; ATENOLOL; DEXTROMETHORPHAN; DIZOCILPINE; KETAMINE; METHYSERGIDE; METOPROLOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NADOLOL; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; OXPRENOLOL; PINDOLOL; POTASSIUM CHANNEL STIMULATING AGENT; PROPRANOLOL; TIMOLOL; TONABERSAT; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

CLINICAL TRIAL; DRUG EFFICACY; DRUG TARGETING; FAMILIAL HEMIPLEGIC MIGRAINE; HEADACHE; HUMAN; LABORATORY TEST; MIGRAINE; MIGRAINE AURA; NEUROIMAGING; NOCICEPTIVE RECEPTOR; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPREADING CORTICAL DEPRESSION;

EID: 28244454750     PISSN: 17435005     EISSN: 17435013     Source Type: Journal    
DOI: 10.1111/j.1743-5013.2005.00017.x     Document Type: Review

References (91)

1. Leao AAP. Spreading depression of activity in cerebral cortex. J Neurophysiol 1944;7:359-390.
2. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 2001;81(3):1065-1096.
3. Ayata C, Shin HK, Salomone S, et al. Pronounced hypoperfusion during spreading depression in mouse cortex. J Cereb Blood Flow Metab 2004;24:1172-1182.
4. Read SJ, Hirst WD, Upton N, et al. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res 2001;891(1-2):69-77.
5. Kunkler PE, Kraig RP. Calcium waves precede electrophysiological changes of spreading depression in hippocampal organ cultures. J Neurosci 1998;18(9):3416-3425.
6. Bures J, Buresova O, Krivanek J, et al. The Mechanism and Applications of Leao's Spreading Depression of Electroencephalographic Activity. New York: Academic Press, 1974.
7. Kruger H, Heinemann U, Luhmann HJ, et al. Effects of ionotropic glutamate receptor blockade and 5-HT1A receptor activation on spreading depression in rat neocortical slices. Neuroreport 1999;10(12):2651-2656.
8. Sramka M, Brozek G, Bures J, et al. Functional ablation by spreading depression: Possible use in human stereotactic neurosurgery. Appl Neurophysiol 1977;40(1):48-61.
9. Avoli M, Drapeau C, Louvel J, et al. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol 1991;30(4):589-596.
10. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001;98(8):4687-4692.
11. Strong AJ. Detecting and characterizing spreading depression in the injured human brain. J Cereb Blood Flow Metab 2003;23(1):748.
12. Strong AJ, Fabricius M, Boutelle MG, et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke 2002;33(12):2738-2743.
13. Mayevsky A, Doron A, Manor T, et al. Cortical spreading depression recorded from the human brain using a multiparametric monitoring system. Brain Res 1996;740(1-2):268-274.
14. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994;117(Pt 1):199-210.
15. D'Esposito M, Deouell LY, Gazzaley A, et al. Alterations in the BOLD fMRI signal with ageing and disease: A challenge for neuroimaging. Nat Rev Neurosci 2003;4(11):863-872.
16. Giffin NJ, Kaube H. The electrophysiology of migraine. Curr Opin Neurol 2002;15(3):303-309.
17. Aurora SK, Barrodale P, Chronicle EP, et al. Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache 2005;45(5):546-552.
18. Bowyer SM, Mason KM, Moran JE, et al. Cortical hyperexcitability in migraine patients before and after sodium valproate treatment. J Clin Neurophysiol 2005;22(1):65-67.
19. Richter F, Mikulik O, Ebersberger A, et al. Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage. J Cereb Blood Flow Metab 2005;25:1225-1235.
20. Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
21. Woods RP, Iacoboni M, Mazziotta JC, et al. Brief report: Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331(25):1689-1692.
22. Reuter U, Bolay H, Jansen-Olesen I, et al. Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain 2001;124(Pt 12):2490-2502.
23. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87(3):543-552.
24. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003;33(2):192-196.
25. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005;366(9483):371-377.
26. Ayata C, Shimizu-Sasamata M, Lo EH, et al. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alphal A subunit of P/Q type calcium channels. Neuroscience 2000;95(3):639-645.
27. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al. A Cacnala knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004;41(5):701-710.
28. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Ann Neurol 2004;55(2):276-280.
29. Anzola GP, Del Sette M, Rozzini L, et al. The migraine-PFO connection is independent of sex. Cerebrovasc Dis 2000;10(2):163.
30. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001;100(2):215-220.
31. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: A new migraine treatment? J Interv Cardiol 2003;16(1):39-42.
32. Morandi E, Anzola GP. Migraine epidemiology, clinical presentations, and comorbidity. Headache 2004;44(7):734-735.
33. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62(8):1399-1401.
34. Wilmshurst PT, Pearson MJ, Nightingale S, et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90(11):1315-1320.
35. Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 2005;45(4):489-492.
36. Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45(4):493-495.
37. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004;113(10):1447-1455.
38. Munno I, Centonze V, Marinaro M, et al. Cytokines and migraine: Increase of IL-5 and IL-4 plasma levels. Headache 1998;38(6):465-67.
39. Iadecola C. From CSD to headache: A long and winding road. Nat Med 2002;8(2):110-112.
40. Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28(6):791-798.
41. Moskowitz MA, Nozaki K, Kraig RP, et al. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993;13(3):1167-1177.
42. Bolay H, Reuter U, DunnAK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002;8(2):136-142.
43. Aoki T, Sumii T, Mori T, et al. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: Mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 2002;33(11):2711-2777.
44. Rosenberg GA, Cunningham LA, Wallace J, et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: Activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 2001;893(1-2):104-112.
45. Leppert D, Waubant E, Galardy R, et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154(9):4379-4389.
46. Chandler S, Miller KM, Clements JM, et al. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview. J Neuroimmunol 1997;72(2):155-161.
47. Jander S, Schroeter M, Peters O, et al. Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab 2001;21(3):218-225.
48. Yong VW, Power C, Forsyth P, et al. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001;2(7):502-511.
49. Tottene A, Fellin T, Pagnutti S, et al. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci U S A 2002;99(20):13284-13289.
50. Caddick SJ, Wang C, Fletcher CF, et al. Excitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4(1h)) and tottering (Cacnalatg) mouse thalami. J Neurophysiol 1999:81(5):2066-2074.
51. Plomp JJ, Vergouwe MN, Van den Maagdenberg AM, et al. Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. Brain 2000;123(Pt3):463-471.
52. Fletcher CF, Lutz CM, O'Sullivan TN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996;87(4):607-617.
53. Doyle J, Ren X, Lennon G, et al. Mutations in the Cacnl1a4 calcium channel gene are associated with seizures, cerebellar degeneration, and ataxia in tottering and leaner mutant mice. Mamm Genome 1997;8(2):113-120.
54. Qian J, Noebels JL. Presynaptic Ca(2+) influx at a mouse central synapse with Ca(2+) channel subunit mutations. J Neurosci 2000;20(1):163-170.
55. Westenbroek RE, Sakurai T, Elliott EM, et al. Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels. J Neurosci 1995;15(10):6403-6418.
56. Dunlap K, Luebke JI, Turner TJ, et al. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci 1995;18(2):89-98.
57. Richter F, Ebersberger A, Schaible HG, et al. Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression. Neurosci Lett 2002;334(2):123-126.
58. Silberstein SD. Sex hormones and headache. Rev Neurol (Paris) 2000;156(Suppl 4):4S30-4S41.
59. Smith SS. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res 1989; 503(2):354-357.
60. Smith SS, Waterhouse BD, Woodward DJ. Sex steroid effects on extrahypothalamic CNS. I. Estrogen augments neuronal responsiveness to iontophoretically applied glutamate in the cerebellum. Brain Res 1987;422(1):40-51.
61. Smith SS. Female sex steroid hormones: From receptors to networks to performance-actions on the sensorimotor system. Prog Neurobiol 1994;44(1):55-86.
62. Smith MJ, Adams LF, Schmidt PJ, et al. Effects of ovarian hormones on human cortical excitability. Ann Neurol 2002;51(5): 599-603.
63. Kaube H, Herzog J, Kaufer T, et al. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000;55:139-141.
64. Nicolodi M, Sicuteri F. Exploration of NMDA receptors in migraine: Therapeutic and theoretic implications. Int J Clin Pharmacol Res 1995;15:181-189.
65. Mitsikostas DD, Sanchez del Rio M. Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Brain Res Rev 2001;35(1):20-35.
66. Gorelova NA, Koroleva VI, Amemori T, et al. Ketamine blockade of cortical spreading depression in rats. Electroencephalogr Clin Neurophysiol 1987;66(4):440-447.
67. Gorji A, Scheller D, Straub H, et al. Spreading depression in human neocortical slices. Brain Res 2001;906(1-2):74-83.
68. van der Hel WS, van den Bergh WM, Nicolay K, et al. Suppression of cortical spreading depressions after magnesium treatment in the rat. Neuroreport 1998;9(10):2179-2182.
69. Van Harreveld A. Compounds in brain extracts causing spreading depression of cerebral cortical activity and contraction of crustacean muscle. J Neurochem 1959;3:300-315.
70. Martinez F, Castillo J, Rodriguez JR, et al. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 1993;13(2):89-93.
71. Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984;309(5965):261-263.
72. Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 1998;5(1):24-27.
73. Kunkler PE, Kraig RP. P/QCa2+ channel blockade stops spreading depression and related pyramidal neuronal Ca2+ rise in hippocampal organ culture. Hippocampus 2004;14(3):356-367.
74. Nedergaard M, Cooper AJ, Goldman SA, et al. Gap junctions are required for the propagation of spreading depression. J Neurobiol 1995;28(4):433-444.
75. Wu YJ, Boissard CG, Greco C, et al. (S)-N-[1-(3-Morpholin-4-ylphenyl) ethyl]-3-phenylacrylamide: An orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine. J Med Chem 2003;46(15):3197-3200.
76. Bradley DP, Smith MI, Netsiri C, et al. Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: Comparison of sumatriptan and tonabersat. Exp Neurol 2001;172(2):342-353.
77. Smith SE, Gottfried JA, Chen JC, et al. Calcium dependence of glutamate receptor-evoked alkaline shifts in hippocampus. Neuroreport 1994;5(18):2441- 2445.
78. Anderson TR, Andrew RD. Spreading depression: Imaging and blockade in the rat neocortical brain slice. J Neurophysiol 2002; 88(5):2713-2725.
79. Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia 2000;20(9):765-786.
80. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 2004;(3):CD003226.
81. Cutrer F, Waeber C, Moskowitz MA, et al. Headache. In Coyle J, ed. Pharmacological Management of Neurological and Psychiatric Disorders. McGraw-Hill 1998:525-568.
82. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004;(2):CD003225.
83. Colombo B, Annovazzi PO, Comi G. Therapy of primary headaches: The role of antidepressants. Neurol Sci 2004;25(Suppl 3):S171-S175.
84. Jin H, Kudo C. Suppression of Cortical Spreading Depression in Migraine Prophylaxis. Washington, D.C.: Society for Neuroscience, 2005.
85. Chen G, Hasanat KA, Bebchuk JM, et al. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom Med 1999;61(5):599-617.
86. Bosetti F, Bell JM, Manickam P. Microarray analysis of rat brain gene expression after chronic administration of sodium valproate. Brain Res Bull 2005;65(4):331-338.
87. Drigues N, Poltyrev T, Bejar C, et al. cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs. J Neural Transm 2003;110(12):1413-1436.
88. Herndon DN, Dasu MR, Wolfe RR, et al. Gene expression profiles and protein balance in skeletal muscle of burned children after beta-adrenergic blockade. Am J Physiol Endocrinol Metab 2003;285(4):E783-E789.
89. Sarang SS, Yoshida T, Cadet R, et al. Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics 2002;11(2):45-52.
90. Marshall E. Getting the noise out of gene arrays. Science 2004; 306(5696):630-631.
91. Kaube H, Goadsby PJ. Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neuro 1994;134:30-35.